Inhibition of mechanical stress-induced hypertrophic scar inflammation by emodin

Molecular Medicine Reports

Volumn 11, Issue 6, 2015, Pages 4087-4092

  Liu, Cheng ^a  

^a Jiangxi Provincial People's Hospital   (China)

Author keywords

Emodin; Hypertrophic scarring; Inflammation; Phosphoinositide 3 kinase Akt

Indexed keywords

3 METHYLADENINE; CONNEXIN 43; PHOSPHOPROTEIN; EMODIN; HERBACEOUS AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; AUTOPHAGY; CONTROLLED STUDY; CYTOPLASM; GAP JUNCTION; HIPPOCAMPUS; IMMUNOFLUORESCENCE; IN VIVO STUDY; LYSOSOME; MALE; NERVE CELL; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TRANSMISSION ELECTRON MICROSCOPY; TRAUMATIC BRAIN INJURY; UPREGULATION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CICATRIX, HYPERTROPHIC; COMPLICATION; DRUG EFFECTS; FEMALE; IMMUNOLOGY; INFLAMMATION; MECHANICAL STRESS; SIGNAL TRANSDUCTION;

RHEUM X HYBRIDUM;

ANIMALS; CICATRIX, HYPERTROPHIC; DRUGS, CHINESE HERBAL; EMODIN; FEMALE; INFLAMMATION; MICE, INBRED C57BL; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STRESS, MECHANICAL;

EID: 84924674608     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3265     Document Type: Article

References (32)

1. Wolfram D, Tzankov A, Pülzl P and Piza-Katzer H: Hypertrophic scars and keloids-A review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg 35: 171-181, 2009.
2. Rahmani-Neishaboor E, Yau FM, Jalili R, Kilani RT and Ghahary A: Improvement of hypertrophic scarring by using topical anti-fibrogenic/anti-inflammatory factors in a rabbit ear model. Wound Repair Regen 18: 401-408, 2010.
3. Huang C, Akaishi S, Hyakusoku H and Ogawa R: Are keloid and hypertrophic scar different forms of the same disorder A fibroproliferative skin disorder hypothesis based on keloid findings. Int Wound J 11: 517-522, 2014.
4. Eming SA, Krieg T and Davidson JM: Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 127: 514-525, 2007.
5. Gauglitz GG, Korting HC, Pavicic T, et al: Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 17: 113-125, 2011.
6. Wynn TA: Cellular and molecular mechanisms of fibrosis. J Pathol 214: 199-210, 2008.
7. van der Veer WM, Bloemen MC, Ulrich MM, et al: Potential cellular and molecular causes of hypertrophic scar formation. Burns 35: 15-29, 2009.
8. Wong VW, Paterno J, Sorkin M, et al: Mechanical force prolongs acute inflammation via T-cell-dependent pathways during scar formation. FASEB J 25: 4498-4510, 2011.
9. Wong VW, Rustad KC, Akaishi S, et al: Focal adhesion kinase links mechanical force to skin fibrosis via inflammatory signaling. Nat Med 18: 148-152, 2011.
10. Krötzsch-Gómez FE, Furuzawa-Carballeda J, Reyes-Márquez R, Quiróz-Hernández E and Díaz de León L: Cytokine expression is downregulated by collagen-polyvinylpyrrolidone in hypertrophic scars. J Invest Dermatol 111: 828-834, 1998.
11. Polo M, Ko F, Busillo F, Cruse CW, Krizek TJ and Robson MC: The 1997 Moyer Award. Cytokine production in patients with hypertrophic burn scars. J Burn Care Rehabil 18: 477-482, 1997.
12. Wei WT, Lin SZ, Liu DL and Wang ZH: The distinct mechanisms of the antitumor activity of emodin in different types of cancer (Review). Oncol Rep 30: 2555-2562, 2013.
13. Shrimali D, Shanmugam MK, Kumar AP, et al: Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer. Cancer Lett 341: 139-149, 2013.
14. Hu Q, Noor M, Wong YF, et al: In vitro anti-fibrotic activities of herbal compounds and herbs. Nephrol Dial Transplant 24: 3033-3041, 2009.
15. Lin YL, Wu CF and Huang YT: Phenols from the roots of Rheum palmatum attenuate chemotaxis in rat hepatic stellate cells. Planta Med 74: 1246-1252, 2008.
16. Aarabi S, Bhatt KA, Shi Y, et al: Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB J 21: 3250-3261, 2007.
17. Liu XJ, Xu MJ, Fan ST, et al: Xiamenmycin attenuates hypertrophic scars by suppressing local inflammation and the effects of mechanical stress. J Invest Dermatol 133: 1351-1360, 2013.
18. Pfaff AW, Georges S and Candolfi E: Different effect of Toxoplasma gondii infection on adhesion capacity of fibroblasts and monocytes. Parasite Immunol 30: 487-490, 2008.
19. Ha MK, Song YH, Jeong SJ, et al: Emodin inhibits proinflammatory responses and inactivates histone deacetylase 1 in hypoxic rheumatoid synoviocytes. Biol Pharm Bull 34: 1432-1437, 2011.
20. Zhang L, Li Y, Liang C and Yang W: CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis. Int J Mol Med 33: 478-486, 2014.
21. Son G, Hines IN, Lindquist J, Schrum LW and Rippe RA: Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis. Hepatology 50: 1512-1523, 2009.
22. Le Cras TD, Korfhagen TR, Davidson C, et al: Inhibition of PI3K by PX-866 prevents transforming growth factor-alpha-induced pulmonary fibrosis. Am J Pathol 176: 679-686, 2010.
23. Son MK, Ryu YL, Jung KH, et al: HS-173, a novel PI3K inhibitor, attenuates the activation of hepatic stellate cells in liver fibrosis. Sci Rep 3: 3470, 2013.
24. Yoon HE, Kim SJ, Kim SJ, Chung S and Shin SJ: Tempol attenuates renal fibrosis in mice with unilateral ureteral obstruction: the role of PI3K-Akt-FoxO3a signaling. J Korean Med Sci 29: 230-237, 2014.
25. van der Veer WM, Ferreira JA, de Jong EH, Molema G and Niessen FB: Perioperative conditions affect long-term hypertrophic scar formation. Ann Plast Surg 65: 321-325, 2010.
26. Kitano A, Saika S, Yamanaka O, et al: Emodin suppression of ocular surface inflammatory reaction. Invest Ophthalmol Vis Sci 48: 5013-5022, 2007.
27. Salgado RM, Alcántara L, Mendoza-Rodríguez CA, et al: Post-burn hypertrophic scars are characterized by high levels of IL-1 mRNA and protein and TNF-type I receptors. Burns 38: 668-676, 2012.
28. Reno F, Sabbatini M, Lombardi F, et al: In vitro mechanical compression induces apoptosis and regulates cytokines release in hypertrophic scars. Wound Repair Regen 11: 331-336, 2003.
29. Dasu MR, Hawkins HK, Barrow RE, Xue H and Herndon DN: Gene expression profiles from hypertrophic scar fibroblasts before and after IL-6 stimulation. J Pathol 202: 476-485, 2004.
30. Song J, Xu H, Lu Q, Xu Z, Bian D, Xia Y, Wei Z, Gong Z and Dai Y: Madecassoside suppresses migration of fibroblasts from keloids: involvement of p38 kinase and PI3K signaling pathways. Burns 38: 677-684, 2012.
31. Lee SU, Shin HK, Min YK and Kim SH: Emodin accelerates osteoblast differentiation through phosphatidylinositol 3-kinase activation and bone morphogenetic protein-2 gene expression. Int Immunopharmacol 8: 741-747, 2008.
32. Wei WT, Chen H, Ni ZL, et al: Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activation. Int J Oncol 39: 1381-1390, 2011.